Can contrast-enhanced ultrasound with perfluorobutane add value in detection of hepatocellular carcinoma in cirrhosis during surveillance? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732065/ Visite: 607 Indietro Avanti